Khadija Saeed

Khadija Saeed

Khadija Saeed is a financial markets reporter at TS2.tech, specializing in stocks, technology and emerging industries. She studied economics and finance at the London School of Economics and previously worked in market research before moving into financial journalism. Her coverage focuses on the companies, innovations and economic trends influencing global investors. Follow Khadija Saeed on Google News.

Amicus Therapeutics (FOLD) Stock Today: BioMarin’s $4.8B Cash Buyout at $14.50 Resets the Outlook (Dec. 20, 2025)

Amicus Therapeutics (FOLD) Stock Today: BioMarin’s $4.8B Cash Buyout at $14.50 Resets the Outlook (Dec. 20, 2025)

December 20, 2025 — Amicus Therapeutics, Inc. has abruptly shifted from a “rare-disease growth story” to a merger-arbitrage stock after BioMarin Pharmaceutical announced a definitive, all-cash acquisition valued at roughly $4.8 billion. The headline number for shareholders: $14.50 per share in cash, a premium of about 33% to Amicus’ prior close. Reuters+2BioMarin Corporate+2
Hecla Mining (HL) Stock News, Forecasts and Analysis for Dec. 20, 2025: Silver Record Highs, S&P MidCap 400 Addition, and What Comes Next

Hecla Mining (HL) Stock News, Forecasts and Analysis for Dec. 20, 2025: Silver Record Highs, S&P MidCap 400 Addition, and What Comes Next

Hecla Mining Company stock is ending 2025 in the spotlight—riding a historic surge in silver prices, fresh company catalysts in Nevada, and a looming index event that could reshape near-term trading flows. As of Dec. 20, 2025, HL is around $19.67 after a volatile day that pushed above $20.50. StockInvest
Newmont Corporation Stock (NEM) News Today: Latest Updates, Gold Price Forecasts, Analyst Targets, and 2026 Outlook (20 December 2025)

Newmont Corporation Stock (NEM) News Today: Latest Updates, Gold Price Forecasts, Analyst Targets, and 2026 Outlook (20 December 2025)

Newmont Corporation is closing out 2025 with momentum that few large-cap miners have matched. In the last completed U.S. session, Newmont shares finished at $101.29, rising 1.96% and ending the day just 0.82% below their 52‑week high of $102.13. Trading activity also jumped: volume hit roughly 27.6 million shares, far above the 50‑day average of about 10.6 million, a sign that institutions and larger traders remain highly engaged in the name into year-end. MarketWatch
20 December 2025
American Express (AXP) Stock News, Forecasts and Analysis for Dec. 20, 2025: Dividend Update, Holiday-Spend Momentum, and What Investors Are Watching Next

American Express (AXP) Stock News, Forecasts and Analysis for Dec. 20, 2025: Dividend Update, Holiday-Spend Momentum, and What Investors Are Watching Next

Dec. 20, 2025 — American Express Company is ending the year near fresh highs as investors weigh two competing narratives: a resilient premium-spending backdrop that continues to support card volumes and fee growth, and a late-2025 policy and payments-industry debate that could reshape how “premium” cards are priced at checkout.
20 December 2025
Philip Morris International (PM) Stock News Today: Dividend, FDA Catalysts, and Wall Street Forecasts as of Dec. 20, 2025

Philip Morris International (PM) Stock News Today: Dividend, FDA Catalysts, and Wall Street Forecasts as of Dec. 20, 2025

Updated: December 20, 2025 — Philip Morris International Inc. stock is ending the week in the spotlight as investors balance a resilient dividend story with a fast-moving U.S. “smoke-free” growth narrative built around ZYN nicotine pouches and the IQOS heated-tobacco platform. While U.S. markets are closed on Saturday, the latest available quote puts PM at $156.84 at the close, with modest after-hours strength. StockAnalysis
20 December 2025
Gilead Sciences Stock (NASDAQ: GILD) Today: TrumpRx Drug-Pricing Deal, HIV Pipeline Momentum, and Wall Street Forecasts (Dec. 20, 2025)

Gilead Sciences Stock (NASDAQ: GILD) Today: TrumpRx Drug-Pricing Deal, HIV Pipeline Momentum, and Wall Street Forecasts (Dec. 20, 2025)

Gilead Sciences, Inc. heads into the weekend with fresh policy headlines, a high-profile pricing agreement tied to the Trump administration’s TrumpRx initiative, and renewed attention on the company’s next-generation HIV portfolio. The combination has kept Gilead stock near the top of its recent trading range—while also reopening the debate investors have wrestled with all year: how much upside can the pipeline deliver, and how much risk does U.S. pricing policy introduce?
Intuit (INTU) Stock News, Forecasts and Analyst Outlook: USDC Stablecoin Deal, TurboTax 2026 Tax Push, and Key Catalysts (Dec. 20, 2025)

Intuit (INTU) Stock News, Forecasts and Analyst Outlook: USDC Stablecoin Deal, TurboTax 2026 Tax Push, and Key Catalysts (Dec. 20, 2025)

Dec. 20, 2025 — Intuit Inc. enters the weekend with investors balancing a fresh fintech headline—Intuit’s newly announced USDC stablecoin partnership with Circle—against the familiar seasonal catalyst that often defines the stock’s narrative: TurboTax demand heading into the 2026 filing season. Intuit Inc.+1
Adobe Stock (ADBE) News on Dec. 20, 2025: Earnings, AI Firefly Expansion, Runway & ChatGPT Deals, Analyst Price Targets, and Lawsuit Risk

Adobe Stock (ADBE) News on Dec. 20, 2025: Earnings, AI Firefly Expansion, Runway & ChatGPT Deals, Analyst Price Targets, and Lawsuit Risk

Adobe Inc. heads into the final full week before year-end with a familiar split-screen story for investors: record results and upbeat fiscal 2026 targets on one side, and growing debate over AI-era competition and legal risk on the other. Over the past 10 days, Adobe has delivered its fiscal Q4 beat and FY2026 outlook, pushed deeper into AI-first workflows through Firefly, announced high-profile integrations with OpenAI’s ChatGPT and AI video specialist Runway, and then faced a new AI training-data lawsuit that could become an overhang for sentiment. Reuters+3Adobe+3Reuters+3
IBM Stock News and Forecast for 2026: IBM Shares Hold Near $301 as Confluent Deal, Credit Outlook, and Analyst Calls Collide (Dec. 20, 2025)

IBM Stock News and Forecast for 2026: IBM Shares Hold Near $301 as Confluent Deal, Credit Outlook, and Analyst Calls Collide (Dec. 20, 2025)

International Business Machines Corporation enters the final stretch of 2025 with its stock consolidating near the $300 level—an area that has become a focal point for both bulls betting on IBM’s “AI + hybrid cloud” strategy and skeptics warning that the company’s acquisition push could strain the balance sheet.
Insmed (INSM) Stock News and Forecasts on Dec. 20, 2025: Brinsupri Trial Miss, Truist Upgrade, and Updated Price Targets

Insmed (INSM) Stock News and Forecasts on Dec. 20, 2025: Brinsupri Trial Miss, Truist Upgrade, and Updated Price Targets

December 20, 2025 — Insmed Incorporated is ending the week in “re-pricing mode” after a mid-stage clinical setback jolted investor expectations, sparked sharp volatility, and triggered a round of analyst price-target revisions. By Friday’s close, Insmed shares finished at $174.84, up about 5% on the day—recovering some ground after Thursday’s steep drop.
Robinhood (HOOD) Stock News, Forecasts and Analysis as of Dec. 20, 2025: Prediction Markets, AI “Cortex,” and Global Expansion Take Center Stage

Robinhood (HOOD) Stock News, Forecasts and Analysis as of Dec. 20, 2025: Prediction Markets, AI “Cortex,” and Global Expansion Take Center Stage

Robinhood Markets, Inc. is closing out mid-December with investor attention locked on a single theme: the company’s rapid shift from a “commission-free broker” into a broader trading-and-betting marketplace, powered by prediction markets, expanding crypto capabilities, and new international growth bets.
20 December 2025
DWP Christmas Payments 2025: Full List of Early Benefit Dates, £10 Christmas Bonus Eligibility, and Jobcentre Opening Times

DWP Christmas Payments 2025: Full List of Early Benefit Dates, £10 Christmas Bonus Eligibility, and Jobcentre Opening Times

London — Saturday, 20 December 2025 — With Christmas and New Year bank holidays approaching, the Department for Work and Pensions and GOV.UK guidance confirms that some benefit and State Pension payments will be made earlier than usual, while Jobcentre Plus offices and key helplines will operate reduced or changed opening hours. Meanwhile, millions of pensioners and eligible benefit claimants have already received the long-running £10 Christmas Bonus, and fact-checkers are warning about viral misinformation claiming the payment is higher.
20 December 2025
1 725 726 727 728 729 891
AI PORTFOLIO

Top Stock Picks

Today’s highest-ranked model selections.

#1 STRONG BUY

Constellation Energy

NASDAQ: CEG 95 / 100
#2 BUY

AerCap

NYSE: AER 93 / 100
#3 BUY

Walt Disney

NYSE: DIS 92 / 100
#4 ACCUMULATE

AIG

NYSE: AIG 90 / 100
#5 BUY ON PULLBACK

Cheniere Energy

NYSE: LNG 88 / 100
View full portfolio
Editorial model selection. Not personalised advice.